new_0222_0458|AVIR|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0458|AVIR|1|Atea Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Atea Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Atea Pharmaceuticals Inc Inventories (Quarterly) (USD)|Atea Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Atea Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Atea Pharmaceuticals Inc Book Value (Quarterly) (USD)|Atea Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Atea Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc EV to Revenues|Atea Pharmaceuticals Inc EV to Earnings|Atea Pharmaceuticals Inc EV to Free Cash Flow|Atea Pharmaceuticals Inc EV to Assets (Quarterly)|Atea Pharmaceuticals Inc PS Ratio|Atea Pharmaceuticals Inc PE Ratio|Atea Pharmaceuticals Inc Price to Book Value|Atea Pharmaceuticals Inc PEG Ratio|Atea Pharmaceuticals Inc Debt to Equity Ratio|Atea Pharmaceuticals Inc Dividend Yield|Atea Pharmaceuticals Inc Shareholder Yield (TTM)|Atea Pharmaceuticals Inc Percent of Shares Outstanding Short|Atea Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc Return on Invested Capital|Atea Pharmaceuticals Inc Quality Ratio Score|Atea Pharmaceuticals Inc Momentum Score|Atea Pharmaceuticals Inc Beta (1Y)|Atea Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Atea Pharmaceuticals Inc Institutional Investor Ownership Percentage|Atea Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Atea Pharmaceuticals Inc Total Employees (Annual)|Atea Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Atea Pharmaceuticals Inc Shares Outstanding|Atea Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Atea Pharmaceuticals Inc Payout Ratio|Atea Pharmaceuticals Inc Quick Ratio (Quarterly)|Atea Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Atea Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Atea Pharmaceuticals Inc Effective Tax Rate (TTM)|Atea Pharmaceuticals Inc Return on Equity|Atea Pharmaceuticals Inc Net Income (TTM) (USD)|Atea Pharmaceuticals Inc Revenue (TTM) (USD)|Atea Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Atea Pharmaceuticals Inc Revenue (Quarterly) (USD)|Atea Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Atea Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Atea Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Net Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Price (USD)|Atea Pharmaceuticals Inc Total Return Price (USD)|Atea Pharmaceuticals Inc Enterprise Value (USD)|Atea Pharmaceuticals Inc 30-Day Average Daily Volume|Atea Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0458|AVIR|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0458|AVIR|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0458|AVIR|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|1.44086021505|0|1.44839857651|91|1.44086021505|1.44090909091|1.44839857651|0|91|1.4520123839|0|15.2666666667|106.5|106.5|106.5|0|0|31|30.6666666667|0|0|91.375|182.5|91.375|31.6666666667|0|106.5|0|91|91.375|0|0|0|91.4|0|0|91|0|91.375|91.375|91.375|91.375|1.4520123839|1.4520123839|1.4520123839|1.45238095238|1.43661971831||
new_0222_0458|AVIR|6|6|6|0|6|0|6|6|6|0|6|6|0|93|0|281|3|93|220|281|0|3|323|0|30|6|6|6|0|0|2|3|0|0|8|2|8|12|0|6|0|3|8|0|0|0|5|0|0|3|0|8|8|8|8|323|323|323|294|71||
new_0222_0458|AVIR|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0458|AVIR|201909||||||||||||||||||||||||||||||||||47.2925||-0.0768||||||-0.0768|||||||||1.358|-3.632|-3.632|0.137|||||||
new_0222_0458|AVIR|201912|21.91|21.661||0.041||71.644|2.435|69.209||-49.571|-54.213||||||||||||||0|0.548|0.01|||||||47.2925||-0.0984|||79.2419|||-0.0984|||||||||1.26|-4.655|-4.655|0.094|||||||
new_0222_0458|AVIR|202003||||||||||||||||||||||||||||||||||47.2925||-0.0843||||||-0.0843|||||||||1.224|-3.988|-3.988|0.057|||||||
new_0222_0458|AVIR|202006|118.45|115.792||0.039||7.127|7.058|0.069||112.618|-68.194|||||||||||||||3.86|0.059|||||||47.2925||-0.2113|||79.2419|||-0.2113||||-22.268|||||2.248|-9.993|-9.993|0.01|||||||
new_0222_0458|AVIR|202009|108.413|105.383||0.049||186.617|10.816|175.801||-76.511|-85.816|||||||||||0||0||4.476|0.01||||||22.1124|79.2419|19|-0.2224|80.7419||79.2419|||-0.2224||||-36.258|||||4.028|-17.622|-17.622|0.007|30.34|30.34|2344.3262|||33.32|
new_0222_0458|AVIR|202012|863.477|850.117||0.048||315.831|315.795|0.036||547.801|-65.16||||8.7422|3.0037|||6.2873||0|0||2.9187|5.815|0.06|0.082|||||||82.4369|39|0.2506|82.4369||82.4369||2.7104|0.2506||||-10.947|||48.633||14.14|20.656|20.656|0.009|41.78|41.78|2594.0967|382401.4333||73|75.36
new_0222_0458|AVIR|202103|840.145|833.751||0.041||254.391|254.278|0.113||586.258|-34.447||||15.0323|5.0857||393.6054|8.7146||0|0||3.7571||3.792|0.083|||||||89.0991||0.34|82.7369||82.7369||3.2789|0.34||||23.754|||65.985||8.759|30.713|30.713|0.058|61.75|61.75|4275.2526|357170||24.71|20.42
new_0222_0458|AVIR|202106|871.11|816.46||0.033||273.682|273.653|0.029||597.861|-32.908||||3.4985|1.1033||55.3344|2.974||0|0||10.4927|50|17.901|0.083|||||||88.0914||0.02|82.7769||82.7769||3.1663|0.02||||35.286|||60.391||11.901|8.739|1.539|0.052|21.48|21.48|961.5878|1631483.4||25.04|29.72
new_0222_0458|AVIR|202109|842.946|839.66||0.026||262.052|262.052|0||581.452|-61.102||9.97|83.838|6.7504|2.4564|14.4428|129.5797|5.0075||0|0||7.7919|0|34.192|0.083|4.2732||1|-4.4349|5.5243||82.8156|56|-0.34|83.0471||83.0471|0|3.2042|-0.34|||5.5243|24.714|207.82||32.811||11.939|-22.094|-28.194|0.053|35.06|35.06|2071.9713|1611427.3|-75.7203|11.64|8.09
new_0222_0458|AVIR|202112|||||||||||||-0.4654||-0.3151||3.6828|33.0417|1.2777|||0||3.1329||||||1|-6.7383||||||||||||||||||||||||8.94|8.94|-96.7219|2088898.2|-78.6022|7.14|6.74